【高盛：升药明康德(02359.HK)目标价至85.5港元 评级“中性”】智通财经APP获悉，高盛发布研报称，将药明康德(02359.HK)全年收入预测上调2.3%至440亿元，主要反映TIDES业务更强劲的增长;2025至27年每股盈利预测分别上调3.8%、4%及3.5%。H股目标价由74.9港元升至85.5港元;A股(603259.SH)目标价由77.3元人民币升至82.4元人民币;予“中性”评级。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.